Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Late-Breaking Science: Breakthrough Strategies in the HF Journey
  • Late-Breaking Science
  • IRONMAN: A Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure With Reduced Ejection Fraction
  • Main Event I
    Set Timezone
Paul R Kalra, Portsmouth Hosp Univ NHS Trust, Portsmouth, United Kingdom; John GF Cleland, Mark C Petrie, Univ of Glasgow, Glasgow, United Kingdom; Philip A Kalra, Northern Care Alliance NHS Fndn Trust, Salford, United Kingdom; Iain C Macdougall, King's Coll Hosp, London, United Kingdom; Pierpaolo Pellicori, Michele Robertson, Univ of Glasgow, Glasgow, United Kingdom; Iain B Squire, Univ of Leicester, Leicester, United Kingdom; Elizabeth A Thomson, Ian Ford, Univ of Glasgow, Glasgow, United Kingdom; The IRONMAN Investigators
Communities
Session Types
Key Sessions
Health Equity

Late-Breaking Science: Breakthrough Strategies in the HF Journey

View on the AHA2022 Site

IRONMAN: A Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure With Reduced Ejection Fraction

Contact the speaker(s) for this session
Main Session